Natáli Tereza Capistrano Costa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Natáli Tereza Capistrano Costa has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Marcelo Zaldini Hernandes
Laboratory of Medicinal Theoretical Chemistry (LQTM), Department of Pharmaceutical Sciences, Federal University of Pernambuco (UFPE), Recife, Brazil
3 shared publications - Eduarda Talita Bramorski Mohr
Department of Clinical Analysis, Center of Health Sciences, Federal University of Santa Catarina (UFSC), Campus Universitario‑Trindade, Florianopolis, Brazil
2 shared publications - Eduardo Monguilhott Dalmarco
Department of Clinical Analysis, Center of Health Sciences, Federal University of Santa Catarina (UFSC), Campus Universitario‑Trindade, Florianopolis, Brazil
2 shared publications - Flora Aparecida Milton
Laboratory of Molecular Pharmacology, School of Health Sciences, University of Brasília (UnB), Brasília, Brazil
2 shared publications - José Roberto Santin
Postgraduate Program in Pharmaceutical Sciences, Universidade Do Vale Do Itajaí (UNIVALI), Itajaí, Brazil
2 shared publications - Larissa Benvenutti
Postgraduate Program in Pharmaceutical Sciences, Universidade Do Vale Do Itajaí (UNIVALI), Itajaí, Brazil
2 shared publications
Latest Publications
- Open Access
- 12 October 2026
- Published by Springer Nature in Inflammopharmacology
- Vol. 34 (11) , 7321-7322
Correction: The anti‑inflammatory activity of 2‑iminothiazolidines: the role of PPAR-γ and M2 macrophage subpopulations
- 12 October 2026
- Published by Springer Nature in Inflammopharmacology
- Vol. 34 (11) , 7321-7322
Open AccessCorrection: The anti‑inflammatory activity of 2‑iminothiazolidines: the role of PPAR-γ and M2 macrophage subpopulations
- Open Access
- 22 April 2026
- Published by Springer Nature in Inflammopharmacology
- Vol. 34 (6) , 3817-3833
The anti‑inflammatory activity of 2‑iminothiazolidines: the role of PPARγ and M2 macrophage subpopulations
Thiazolidine derivatives exert anti-inflammatory effects by inhibiting the NF-κB pathway and promoting macrophage polarization toward the anti-inflammatory M2 phenotype, partially through PPARγ activation. Our previous work identified thiazolidine derivative 13 [methyl 2-(benzoylimino)-3-methyl-4-(4-nitrobenzyl)-1,3-thiazolidine-4-carboxylate] as a potent immunomodulator that reduces pro-inflammatory mediators and enhances anti-inflammatory markers. However, its direct interaction with PPARγ remains unclear. This study aims to evaluate whether thiazolidine 13 activates PPARγ and contributes to M2 macrophage polarization using LPS-stimulated RAW 264.7 cells, cell transactivation assay and reporter gene (Hella cells), LPS-stimulated THP-1 cells, and molecular docking analysis. Compound 13 reduced NO₂⁻ production, CD80 expression, and pro-inflammatory cytokines while increasing IL-10, TGF-β, and CD206 in LPS-stimulated RAW 264.7 macrophages. Compound 13 also inhibited NO production in LPS-stimulated THP-1 cells. These effects were only partially reversed by PPARγ antagonists, suggesting additional PPARγ-independent mechanisms, while the induction of CD206 was closely linked to partial PPARγ activation. Docking studies supported this profile, showing that the (S) enantiomer of thiazolidine 13 adopts a binding mode typical of partial PPARγ agonists and exhibits a higher predicted affinity than the (R) enantiomer. Compound 13 acts as a partial PPARγ modulator capable of shifting macrophages from a pro-inflammatory toward an anti-inflammatory phenotype (M2-like). This dual action relies on the inhibition of NF-κB signaling and partial PPARγ activation. The predominance of the M2-like subpopulation, underscores its role in resolving inflammation and promoting tissue repair. Graphical abstract The alternative text for this image may have been generated using AI.
- 22 April 2026
- Published by Springer Nature in Inflammopharmacology
- Vol. 34 (6) , 3817-3833
Open AccessThe anti‑inflammatory activity of 2‑iminothiazolidines: the role of PPARγ and M2 macrophage subpopulations
Thiazolidine derivatives exert anti-inflammatory effects by inhibiting the NF-κB pathway and promoting macrophage polarization toward the anti-inflammatory M2 phenotype, partially through PPARγ activation. Our previous work identified thiazolidine derivative 13 [methyl 2-(benzoylimino)-3-methyl-4-(4-nitrobenzyl)-1,3-thiazolidine-4-carboxylate] as a potent immunomodulator that reduces pro-inflammatory mediators and enhances anti-inflammatory markers. However, its direct interaction with PPARγ remains unclear. This study aims to evaluate whether thiazolidine 13 activates PPARγ and contributes to M2 macrophage polarization using LPS-stimulated RAW 264.7 cells, cell transactivation assay and reporter gene (Hella cells), LPS-stimulated THP-1 cells, and molecular docking analysis. Compound 13 reduced NO₂⁻ production, CD80 expression, and pro-inflammatory cytokines while increasing IL-10, TGF-β, and CD206 in LPS-stimulated RAW 264.7 macrophages. Compound 13 also inhibited NO production in LPS-stimulated THP-1 cells. These effects were only partially reversed by PPARγ antagonists, suggesting additional PPARγ-independent mechanisms, while the induction of CD206 was closely linked to partial PPARγ activation. Docking studies supported this profile, showing that the (S) enantiomer of thiazolidine 13 adopts a binding mode typical of partial PPARγ agonists and exhibits a higher predicted affinity than the (R) enantiomer. Compound 13 acts as a partial PPARγ modulator capable of shifting macrophages from a pro-inflammatory toward an anti-inflammatory phenotype (M2-like). This dual action relies on the inhibition of NF-κB signaling and partial PPARγ activation. The predominance of the M2-like subpopulation, underscores its role in resolving inflammation and promoting tissue repair. Graphical abstract The alternative text for this image may have been generated using AI.
- Open Access
- 5 October 2025
- Published by SAGE Publications in Bioinformatics and Biology Insights
- Vol. 19
Evaluation of the Antigenic Potential of Epitopes Derived From Leishmania braziliensis
Background: Leishmaniasis is a neglected tropical disease caused by protozoa of the genus Leishmania, predominantly affecting populations with limited socioeconomic resources. Leishmania (V.) braziliensis is one of the primary etiological agents for cutaneous leishmaniasis (CL) in Brazil. This study aims to evaluate the interactions between IgG antibodies and 10 antigens derived from L braziliensis for diagnostic applications. These antigens were selected using in silico reverse vaccinology approaches, based on previous research conducted by our group. Methods: A total of 124 IgG antibody structures were retrieved from the SAbDab database. Antigen-antibody (Ag-Ab) complexes were subjected to molecular docking analyses using the SnugDock protocol implemented in the Rosetta platform. In parallel, enzyme-linked immunosorbent assays (ELISA) were performed to assess the diagnostic performance of the selected peptides in detecting active CL. Results: Peptides VIII, VI, V, and I showed the most favorable docking scores, indicating a higher predicted binding affinity with IgG. In ELISA assays, sensitivity values ranged from 0% to 96%, whereas specificity varied from 29% to 86%. Peptides III, IV, and V demonstrated the highest sensitivity, achieving values of 96%, 96%, and 94%, respectively. Conclusions: Considering both in silico and in vitro results, peptides IV and V corroborate significatively, demonstrating higher predicted affinity (more negative docking score values) with the set of antibodies (Ab) used in calculations.
- 5 October 2025
- Published by SAGE Publications in Bioinformatics and Biology Insights
- Vol. 19
Open AccessEvaluation of the Antigenic Potential of Epitopes Derived From Leishmania braziliensis
Background: Leishmaniasis is a neglected tropical disease caused by protozoa of the genus Leishmania, predominantly affecting populations with limited socioeconomic resources. Leishmania (V.) braziliensis is one of the primary etiological agents for cutaneous leishmaniasis (CL) in Brazil. This study aims to evaluate the interactions between IgG antibodies and 10 antigens derived from L braziliensis for diagnostic applications. These antigens were selected using in silico reverse vaccinology approaches, based on previous research conducted by our group. Methods: A total of 124 IgG antibody structures were retrieved from the SAbDab database. Antigen-antibody (Ag-Ab) complexes were subjected to molecular docking analyses using the SnugDock protocol implemented in the Rosetta platform. In parallel, enzyme-linked immunosorbent assays (ELISA) were performed to assess the diagnostic performance of the selected peptides in detecting active CL. Results: Peptides VIII, VI, V, and I showed the most favorable docking scores, indicating a higher predicted binding affinity with IgG. In ELISA assays, sensitivity values ranged from 0% to 96%, whereas specificity varied from 29% to 86%. Peptides III, IV, and V demonstrated the highest sensitivity, achieving values of 96%, 96%, and 94%, respectively. Conclusions: Considering both in silico and in vitro results, peptides IV and V corroborate significatively, demonstrating higher predicted affinity (more negative docking score values) with the set of antibodies (Ab) used in calculations.